Published in JAMA on March 13, 1987
From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol (2010) 3.46
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J Virol (1989) 1.85
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol (1995) 1.63
Polio vaccine: is it time for a change? Arch Dis Child (1998) 1.59
High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J Virol (1994) 1.52
A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas. Am J Public Health (1989) 1.44
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog (2007) 1.31
Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses. J Virol (1993) 1.30
Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev (1998) 1.26
A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol (2005) 1.23
Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area. Bull World Health Organ (1994) 1.15
Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks. Am J Public Health (1988) 1.06
Estimating the extent of vaccine-derived poliovirus infection. PLoS One (2008) 1.05
Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus. Adv Virus Res (2010) 0.96
Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function. Proc Natl Acad Sci U S A (1996) 0.94
Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus. J Virol (1995) 0.91
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
Poliomyelitis: eradication in sight. Epidemiol Infect (1992) 0.85
The wizard and the gatekeeper: of castles and contracts. BMJ (1995) 0.84
Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report. BMJ (1999) 0.82
Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J Clin Microbiol (2006) 0.82
Acute paralytic illness. Postgrad Med J (1996) 0.81
Neurovirulence of type 1 polioviruses isolated from sewage in Japan. Appl Environ Microbiol (2002) 0.81
Characteristics of an environmentally monitored prolonged type 2 vaccine derived poliovirus shedding episode that stopped without intervention. PLoS One (2013) 0.79
Baseline patterns of bone scintigraphy in patients with established post-poliomyelitis paralysis. Skeletal Radiol (2009) 0.78
Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice. J Virol (2003) 0.78
Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation. Ochsner J (2012) 0.77
Immunizations for foreign travel. Yale J Biol Med (1993) 0.75
Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program. Am J Public Health (1996) 0.75
Vaccine-associated paralytic poliomyelitis: a case report of flaccid monoparesis after oral polio vaccine. J Korean Med Sci (2007) 0.75
1889 to 1989: a century of health and disease. Public Health Rep (1990) 0.75
Recurrent and Sustained Viral Infections in Primary Immunodeficiencies. Front Immunol (2017) 0.75
Chronic fatigue syndrome: a working case definition. Ann Intern Med (1988) 9.12
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 8.51
The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health (1997) 7.81
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med (1996) 4.86
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
The impact of influenza epidemics on hospitalizations. J Infect Dis (2000) 4.28
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA (1982) 3.69
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med (2000) 3.65
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev (1988) 3.51
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol (1979) 3.36
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med (1984) 3.22
Reye's syndrome in the United States from 1981 through 1997. N Engl J Med (1999) 3.20
AIDS and absolutism--the demand for perfection in prevention. N Engl J Med (1992) 3.03
Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics (1978) 2.98
The opportunity and obligation to eliminate measles from the United States. JAMA (1979) 2.93
Genetic co-regulation of galactose and melibiose utilization in Saccharomyces. J Bacteriol (1976) 2.92
Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics (1993) 2.74
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology (1981) 2.64
Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health (1985) 2.58
The immunization system in the United States - the role of school immunization laws. Vaccine (1999) 2.57
Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg (1988) 2.57
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol (1981) 2.54
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
The sample household health interview survey. Am J Public Health (1982) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA (1996) 2.26
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J (1987) 2.13
Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12
Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive Services. Am J Prev Med (2000) 2.10
Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol (1985) 2.09
Creutzfeldt-Jakob disease in the United States: 1979-1998. JAMA (2000) 2.09
Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev (1999) 2.09
Use of health services. Am J Public Health (1982) 2.06
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
The health and economic burden of cigarette smoking in Georgia in 1985. J Med Assoc Ga (1989) 1.94
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Progress in measles elimination. JAMA (1982) 1.87
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Low measles incidence: association with enforcement of school immunization laws. Am J Public Health (1981) 1.79
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Current features of measles in the United States: feasibility of measles elimination. Epidemiol Rev (1980) 1.76
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Costs of care. Am J Public Health (1982) 1.74
The resurgence of measles in the United States, 1989-1990. Annu Rev Med (1992) 1.72
Costs of immunization registries: experiences from the All Kids Count II Projects. Am J Prev Med (2000) 1.72
The case for global eradication of poliomyelitis. Bull World Health Organ (1987) 1.72
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study. JAMA (1994) 1.71
Health impact of measles vaccination in the United States. Pediatrics (1985) 1.71
Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71
Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures. Am J Public Health (1987) 1.70
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Outbreak of paralytic poliomyelitis, Taiwan. Lancet (1984) 1.68
Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med (1997) 1.67
Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet (1990) 1.67
Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J (1989) 1.67